Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

NCT02282358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Lymphoma
Relapsed and Refractory
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Interventions

DRUG: Mocetinostat

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]